National Cancer Institute
Cancer Control & Population Sciences Home - NCI's Bridge to Public Health Research, Practice and Policy

Grant Details

Grant Number: 7R03CA072393-02 Interpret this number
Primary Investigator: Holcombe, Randall
Organization: University Of California Irvine
Project Title: Immunomodulation By Levamisole for Cancer Detection
Fiscal Year: 1997
Back to top


Abstract

An abstract does not currently exist for this grant

Back to top


Publications

Investigating the role of immunomodulation for colon cancer prevention: results of an in vivo dose escalation trial of levamisole with immunologic endpoints.
Authors: Holcombe RF, Milovanovic T, Stewart RM, Brodhag TM
Source: Cancer Detect Prev, 2001;25(2), p. 183-91.
PMID: 11341354
Related Citations

Grant Numbers:
NCI NIH HHS - CA72393

MeSH Terms:
Interferon-gamma Neoplasm Staging Dose-Response Relationship, Drug
Humans Adjuvants, Immunologic Pilot Projects
Lymphocytes Cytotoxicity, Immunologic Immunity, Cellular
Antigens, CD Adult Cytokines
Enzyme-Linked Immunosorbent Assay Middle Aged Levamisole
Colonic Neoplasms Th1 Cells Male
Female

Back to top




Last Updated: August 24, 2012
NIH - Turning Discovery Into Health
National Cancer InstituteU.S. National Institutes of HealthNational Cancer Institute